Trial
NCT03594045
Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
Bristol-Myers Squibb
Condition
Heparin-induced Thrombocytopenia
Intervention
Apixaban
Why stopped
Withdrawal of funding by sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-23